Correlation Between Pfizer and CCCB Bancorp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and CCCB Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and CCCB Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and CCCB Bancorp, you can compare the effects of market volatilities on Pfizer and CCCB Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of CCCB Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and CCCB Bancorp.

Diversification Opportunities for Pfizer and CCCB Bancorp

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and CCCB is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and CCCB Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CCCB Bancorp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with CCCB Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CCCB Bancorp has no effect on the direction of Pfizer i.e., Pfizer and CCCB Bancorp go up and down completely randomly.

Pair Corralation between Pfizer and CCCB Bancorp

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the CCCB Bancorp. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.41 times less risky than CCCB Bancorp. The stock trades about -0.07 of its potential returns per unit of risk. The CCCB Bancorp is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  1,036  in CCCB Bancorp on August 30, 2024 and sell it today you would lose (456.00) from holding CCCB Bancorp or give up 44.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy86.87%
ValuesDaily Returns

Pfizer Inc  vs.  CCCB Bancorp

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
CCCB Bancorp 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CCCB Bancorp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, CCCB Bancorp may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pfizer and CCCB Bancorp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and CCCB Bancorp

The main advantage of trading using opposite Pfizer and CCCB Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, CCCB Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CCCB Bancorp will offset losses from the drop in CCCB Bancorp's long position.
The idea behind Pfizer Inc and CCCB Bancorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals